8 Recruiting Hemophilia A Phase 3 Clinical Trials
Active phase 3 studies for hemophilia a enrolling across the USA. Verify eligibility and contact site coordinators.
All Hemophilia A studiesPhase 3 Studies for Hemophilia A
🔵 Active, Not Recruiting Phase3
Long-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia A
📍 Orthopaedic Institute for Children Site Number : 8400003 — Los Angeles, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
Study to Evaluate the Efficacy and Safety of PF-07055480 / Giroctocogene Fitelparvovec Gene Therapy in Moderately Severe to Severe Hemophilia A Adults
📍 NOW Physical Therapy — Mountain View, California
View Study & Checklist ➔ 🟢 Recruiting Phase3
A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
📍 Intermountain - Primary Children's Hospital — Salt Lake City, Utah
View Study & Checklist ➔ 🟢 Recruiting Phase3
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
📍 The Regents of the University of California||UC Davis Health — Rancho Cordova, California
View Study & Checklist ➔ 🟢 Recruiting Phase3
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
📍 University of Iowa — Iowa City, Iowa
View Study & Checklist ➔ 🟢 Recruiting Phase3
A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
📍 Center for Inherited Blood Disorders — Orange, California
View Study & Checklist ➔ 🟢 Recruiting Phase3
SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis
📍 Children's Healthcare of Atlanta — Atlanta, Georgia
View Study & Checklist ➔ 🟢 Recruiting Phase3
A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
📍 University of Colorado Hemophilia and Thrombosis Center — Aurora, Colorado
View Study & Checklist ➔